secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARROW, INC. (HROW)
CIK:        0001360214
Form:       8-K
Filed at:   2022-12-20T23:59:59+00:00
Accession:  0001493152-22-036016
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harrow Health issues $35M 11.875% notes and $100M loan facility for acquisition
-------------------------------------------------------------------------------

- Issued $35M in 11.875% senior notes due 2027 (plus up to $5.25M overallotment); closed Dec 20, 2022.
- Entered $100M loan facility at 10.875% through B. Riley Commercial Capital; matures Dec 14, 2025.
- Loan proceeds earmarked for acquisition of certain assets from Novartis Technology and Novartis Innovative Therapies.
- Loan secured by IP and all assets of Harrow and its material subsidiaries; includes prepayment penalties.
- Notes callable at Company's option starting Dec 31, 2024 at specified prices plus accrued interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1360214/000149315222036016/0001493152-22-036016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1360214/000149315222036016/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-036016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer